President Donald Trump wants to bring additional drug manufacturing to the United States and has threatened tariffs on imported medicine. The U.S. relies heavily on imports for low-cost generics, and building up domestic supply chain capacity could be tricky. We'll map out drug manufacturing and explore what it'd take to reshore drug supplies. But first: oil giants are eager to drill off the coast of Guyana, and the boss of an obscure regulatory agency is stepping down.